Nanomedicine is emerging as a promising approach for diagnostic applications.
Nanoparticles are structures in the nanometer size range, which can present different …

Ischemic diseases such as myocardial infarction, ischemic stroke, and critical limb ischemia
are immense public health challenges. Current pharmacotherapy and surgical approaches …

Cardiovascular disease is the leading cause of death around the world, in which myocardial
infarction (MI) is a precipitating event. However, current therapies do not adequately address …

Cardiovascular disease usually triggers coronary heart disease, stroke, and ischemic
diseases, thus promoting the development of functional failure. Mesenchymal stem cells …

Cardiovascular diseases (CVDs) remain one of the major causes of mortality worldwide. In
response to this and other worldwide health epidemics, nanomedicine has emerged as a …

Background Fibrin-rich clot formation in thrombo-occlusive pathologies is currently treated
by systemic administration of plasminogen activators (eg tPA), to convert fibrin-associated …

Cardiovascular and related diseases (CVRDs) are among the most prevalent chronic
diseases in the 21st century, with a high mortality rate. This review summarizes the various …

Nanoparticles (NPs) are tiny particles with a diameter of less than 100 nm. Traffic exhaust is
a major source of combustion-derived NPs (CDNPs), which represent a significant …

Selenium is capable of forming a dynamic covalent bond with itself and other elements and
can undergo metathesis and regeneration reactions under optimum conditions. Its dynamic …

Coronary arterial disease (CAD) remains the leading cause of death globally. Percutaneous
coronary interventions are frequently used nonsurgical techniques for treating CAD, which …